apollo
logo
0Login
Introducing Our Latest Arrival!
Rejunuron DN Tablet 10's

Rejunuron DN Tablet 10's

Not for online sale
Prescription drug
 Trailing icon
Consult Doctor

Consume Type

ORAL

Return Policy

Not Returnable

Expires on or after

Jan-25

for this medicine

About Rejunuron DN Tablet

Rejunuron DN Tablet belongs to the class of medications ‘anticonvulsants’ used in the treatment of neuropathic pain. Neuropathic pain is a chronic (long-term) progressive nerve disease that causes nerve pain due to nerve damage or the nervous system's malfunctioning. It is mostly seen in patients who had suffered a trauma or nerve injury, diabetes, vitamin deficiencies, cancer, multiple sclerosis (disease of the brain and spinal cord), shingles (a viral infection), and HIV.

Rejunuron DN Tablet is a combination of two medicines: Pregabalin and Methylcobalamin. Pregabalin acts by decreasing the pain signals sent by a damaged nerve in the body. On the other hand, Methylcobalamin helps rejuvenate and protect damaged nerve cells by producing a substance called myelin (outer protective layer of nerve cell - neuron).

You should take this medicine as prescribed by your doctor. The common side-effects of Rejunuron DN Tablet are dizziness, drowsiness, headache, anorexia (loss of appetite), nausea or vomiting, diarrhea, headache, hot sensation (burning pain), vision problems, and diaphoresis (sweating). Inform your doctor if any of these side effects persist.

Do not take Rejunuron DN Tablet if you are allergic to ‘Pregabalin’ and ‘Methylcobalamin’ or any contents before taking Rejunuron DN Tablet if you have a history of heart diseases, liver or kidney disease, alcoholism, or drug abuse.  It should not be used in children and adolescents below 18 years. Inform your doctor if you are pregnant and breastfeeding. Do not drive or operate heavy machinery as Rejunuron DN Tablet may cause dizziness or drowsiness. Rejunuron DN Tablet contains lactose, so inform your doctor if you have any intolerance to sugars. Do not discontinue treatment without telling your doctor. 

Uses of Rejunuron DN Tablet

Treatment of Neuropathic pain.

Medicinal Benefits

Rejunuron DN Tablet is a combination of two drugs: Pregabalin and Methylcobalamin. Pregabalin is an anticonvulsant that affects the brain's chemicals that send pain signals across the nervous system. It works by binding to the specific site on voltage-gated calcium channels (responsible for excitatory response), thereby decreasing brain activity. This effect helps in relieving nerve pain and lowers the risk of seizures. On the other hand, Methylcobalamin is a form of vitamin B12 that helps rejuvenate and protect damaged nerve cells by producing a substance called myelin (outer protective layer of nerve cells). Together, Rejunuron DN Tablet helps in providing relief from neuropathic pain and improved nerve signal conduction.  

 

Directions for Use

Swallow the medicine as a whole with water; do not crush, break or chew it.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Rejunuron DN Tablet

  • Dizziness
  • Drowsiness
  • Headache
  • Anorexia (loss of appetite)
  • Nausea or vomiting
  • Diarrhea
  • Headache
  • Sore throat
  • Vision problems
  • Hot sensation (burning pain)
  • Diaphoresis (sweating)
  • Weight gain

Drug Warnings

Rejunuron DN Tablet may increase the risk of heart failure in patients with heart diseases. It may cause dizziness and somnolence (sleepiness). So, it might increase the risk of accidental injury in elderly patients. Rejunuron DN Tablet may also cause temporary vision problems. However, if this condition is persistent, consult your doctor immediately. Patients with diabetes who gain weight with Rejunuron DN Tablet may need a change in diabetic medicines. If you notice decreased urination while taking Rejunuron DN Tablet , inform your doctor as Rejunuron DN Tablet may cause kidney failure in some cases. It may increase suicidal tendencies, though it is rare. You may experience convulsions after discontinuing Rejunuron DN Tablet . In such cases, inform your doctor immediately.  

Drug Interactions

Drug-Drug Interaction: Rejunuron DN Tablet may interact with a pain killer (oxycodone), opioids, antianxiety drugs (lorazepam), antacid (omeprazole), antibiotic (neomycin), and anti-gout medication (colchicine). 

Drug-Food Interaction: Avoid alcohol consumption while using Rejunuron DN Tablet . 

Drug-Disease Interaction: Rejunuron DN Tablet should be used with caution in patients with liver diseases, kidney diseases, heart problems, alcoholism, drug abuse, and suicidal tendencies. 

Drug-Drug Interactions Checker List

  • OXYCODONE
  • LORAZEPAM
  • OMEPRAZOLE
  • COLCHICINE
  • NEOMYCIN

Habit Forming

Yes

Diet & Lifestyle Advise

  • Include food rich in vitamin B and D in your diet.

  • Include cayenne pepper in your diet as it can help in lowering neuropathic pain.

  • Exercising regularly helps in improving overall health and combating pain.

  • Rest well, get plenty of sleep.

  • Try taking a warm bath as it can be soothing.

  • Avoid smoking and alcohol consumption.

  • Meditation and yoga can help lower stress, decrease pain sensitivity, and improves coping skills.

  • Acupuncture can be helpful by stimulating pressure points.

  • Using essential oils for massages can help increase circulation.

 

Special Advise

  • Rejunuron DN Tablet may increase suicidal thoughts. Extreme caution is advised with people suffering from suicidal tendencies or psychological problems.

  • Rejunuron DN Tablet is known to cause dizziness and sleepiness, so it is advised to refrain from driving or doing any work that requires attention or concentration.

Disease/Condition Glossary

Neuropathic pain: Neuropathic pain is caused due to damage to sensory nerves. It is caused by chronic progressive nerve disease, infection, or injury. The pain could be intermittent or continuous, which is felt as a prickling, stabbing, tingling, or burning sensation. A feeling of numbness and loss of sense is also a common symptom of neuropathic pain. Usually, the body sends the pain signals when there is an injury, but with neuropathic pain, the pain is not triggered by an injury, the body unpromptedly sends the pain signals. Symptoms include spontaneous, untriggered pain, unpleasant feeling, shooting, burning or stabbing pain, difficulty resting or sleeping, and evoked pain (pain caused by events usually not painful).

bannner image

Alcohol

Caution

Alcohol may worsen the condition by increasing the risk of side-effects.

bannner image

Pregnancy

Unsafe

Rejunuron DN Tablet is a category C medicine. It is not recommended for use in pregnant women unless the doctor thinks the benefits outweigh the risks.

bannner image

Breast Feeding

Caution

Rejunuron DN Tablet should be used with caution in breastfeeding mothers unless the doctor thinks the benefits outweigh the risks.

bannner image

Driving

Caution

Rejunuron DN Tablet may cause dizziness and drowsiness. So, avoid driving or operating heavy machinery while using Rejunuron DN Tablet .

bannner image

Liver

Caution

Rejunuron DN Tablet should be used with caution in patients with liver diseases. Dose adjustments may be necessary.

bannner image

Kidney

Caution

Rejunuron DN Tablet should be used with caution in patients with kidney diseases. Dose adjustments may be necessary

bannner image

Children

Unsafe

Rejunuron DN Tablet is not recommended for anyone below the age of 18 years.

Country of origin

India

Manufacturer/Marketer address

#1, Fourrts Avenue, Annai Indira Nagar, Okkiyam Thoraipakkam, Chennai, India.
Other Info - REJ0095

Author Details

Doctor imageWe provide you with authentic, trustworthy and relevant information

FAQs

Rejunuron DN Tablet is used in the treatment of neuropathic pain, a chronic (long-term) progressive nerve disease that causes nerve pain due to nerve damage or the nervous system's malfunctioning.
Rejunuron DN Tablet is a combination of two medicines: Pregabalin and Methylcobalamin. Rejunuron DN Tablet block the brain's pain signals and protect nerve cells from further damage, thereby improving nerve signal conduction to the whole body parts. These effects help to reduce pain in patients with neuropathic pain.
Rejunuron DN Tablet should not be given to children and adolescents under the age of 18 years as it may increase suicidal thoughts.
Rejunuron DN Tablet should not be stopped abruptly as it may cause withdrawal reactions such as trouble sleeping, headache, nausea, feeling anxious, diarrhea, flu-like symptoms, convulsions, nervousness, depression, pain, sweating, and dizziness. Rejunuron DN Tablet should be stopped gradually over a minimum of 1 week.
Rejunuron DN Tablet can be used in patients with diabetes if they have neuropathic pain. However, inform your doctor if you notice any weight gain while using Rejunuron DN Tablet . Your doctor may change your diabetic medicines to stop weight gain. Also, take some measures to control weight such as eating a balanced diet and exercising regularly.
Rejunuron DN Tablet may cause drowsiness. So, it is advised to refrain from activities such as driving or operating heavy machinery if you feel sleepy after taking Rejunuron DN Tablet .
You may notice pain improvement within 2-3 days after taking Rejunuron DN Tablet . However, it may take 2-3 months for your symptoms to improve depending on your health condition.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.